Please complete the CAPTCHA to continue
@biosion.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Mingjiu Chen is listed as Founder, Chairman and CEO @ Biosion, Inc. | Ph.D. Molecular Medicine at Biosion, Inc., based in Nanjing, Jiangsu, China. AeroLeads shows a work email signal at biosion.com and a matched LinkedIn profile for Mingjiu Chen.
Mingjiu Chen previously worked as Founder, Chairman and CEO at Biosion, Inc. and President & CEO at Biosynergics Inc.. Mingjiu Chen holds Ph.D., Molecular Medicine from Ut Health San Antonio.
This section adds company-level context without repeating Mingjiu Chen's masked contact details.
AeroLeads found 1 current-domain work email signal for Mingjiu Chen. Compare company email patterns before reaching out.
At Biosion, Inc., our team's dedication to advancing therapeutic discoveries for oncology and immunological diseases is a testament to our culture of innovation. With a profound expertise in pharmaceutical development, I spearhead the strategic direction and operations of a clinical-stage biotechnology company renowned for its proprietary antibody platforms and robust pipeline of biologics.My role encompasses nurturing collaborations with industry partners, orchestrating R&D initiatives, and steering business development. Skills in attracting world-class talents, developing robust discovery engine, and building up global alliance are crucial to our success, as is our commitment to regulatory excellence and fostering scientific breakthroughs that address unmet medical needs.
Listed skills include Operations Management, Team Management, Biotechnology, Monoclonal Antibodies, and 30 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Nanjing, Jiangsu, CN
Biosion, Inc. is a global clinical-stage biotechnology company discovering and developing innovative therapeutics for oncology and immunological diseases. Leveraging our proprietary H³ (High-throughput, High-content, High-efficiency) antibody platform, SynTracer™ HT-endocytosis platform, and Flexibody™ bifunctional antibody platform, Biosion is committed.
Newark, DE, US
- Led team for customer-based innovative antibody development and antibody scale-up production - Managed discovery programs to ensure the delivery of contracts to meet or exceed the customer expectations
North Chicago, Illinois, US
- Developed advanced antibody platform for robust hybridoma-based therapeutic antibody discovery - Developed and validated single-target-synergistic dual-variable-domain-Ig (STS-DVD-Ig) concept- Accomplished multiple antibody development programs including cancer, immunology, and anti-Id
The Woodlands, TX, US
- Established monoclonal antibody development capability- Accomplished multiple surrogate antibody programs in neurology, immunology and cancer diseases
Quick answers generated from the profile data available on this page.
Mingjiu Chen works for Biosion, Inc..
Mingjiu Chen is listed as Founder, Chairman and CEO @ Biosion, Inc. | Ph.D. Molecular Medicine at Biosion, Inc..
AeroLeads has found 1 work email signal at @biosion.com for Mingjiu Chen at Biosion, Inc..
Mingjiu Chen is based in Nanjing, Jiangsu, China while working with Biosion, Inc..
Mingjiu Chen has worked for Biosion, Inc., Biosynergics Inc., Strategic Diagnostics (D/B/A Sdix), Abbvie, and Lexicon Pharmaceutical.
You can use AeroLeads to view verified contact signals for Mingjiu Chen at Biosion, Inc., including work email, phone, and LinkedIn data when available.
Mingjiu Chen holds Ph.D., Molecular Medicine from Ut Health San Antonio.
Mingjiu Chen is listed with skills including Operations Management, Team Management, Biotechnology, Monoclonal Antibodies, Immunology, Immunoassays, Enzyme Assays, and Molecular Cloning.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts